REGENXBIO Inc. (RGNX) Free cash flow 2016–2025
REGENXBIO Inc. (RGNX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$126.4MFY2025 · since FY2016: -$56.7M → -$126.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$126.4M | +28.0% |
| FY2024 | -$175.6M | +23.1% |
| FY2023 | -$228.4M | +4.1% |
| FY2022 | -$238.2M | -276.8% |
| FY2021 | $134.7M | +266.4% |
| FY2020 | -$80.9M | +32.2% |
| FY2019 | -$119.4M | -230.7% |
| FY2018 | $91.4M | +240.2% |
| FY2017 | -$65.2M | -14.9% |
| FY2016 | -$56.7M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More RGNX financial trends
RGNX RevenueRGNX Net incomeRGNX Net marginRGNX Gross profitRGNX Gross marginRGNX Operating incomeRGNX Operating marginRGNX Operating cash flowRGNX Capital expendituresRGNX Return on equityRGNX Stock buybacksRGNX Dividends paidRGNX Total assetsRGNX Total liabilitiesRGNX Shareholders’ equityRGNX overview →